Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
…, N Betteridge, H Bijlsma, H Burkhardt… - Annals of the …, 2016 - ard.bmj.com
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
…, GM Alenius, NJ McHugh, G Novelli, H Burkhardt… - Nature …, 2010 - nature.com
Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic
arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity …
arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity …
Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis
H Burkhardt, B Sehnert, R Bockermann… - European journal of …, 2005 - Wiley Online Library
Collagen type II (CII) is a relevant joint‐specific autoantigen in the pathogenesis of
rheumatoid arthritis (RA). Whereas the reasons for the breakage of self tolerance to this major …
rheumatoid arthritis (RA). Whereas the reasons for the breakage of self tolerance to this major …
Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis
…, E Bajtner, Å Engström, G Serre, H Burkhardt… - Journal of Experimental …, 2009 - rupress.org
Antibodies to citrulline-modified proteins have a high diagnostic value in rheumatoid arthritis
(RA). However, their biological role in disease development is still unclear. To obtain insight …
(RA). However, their biological role in disease development is still unclear. To obtain insight …
Epitope‐specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen‐induced …
H Burkhardt, T Koller, Å Engström… - Arthritis & …, 2002 - Wiley Online Library
Objective To analyze the fine specificity of IgG autoantibodies in sera from rheumatoid
arthritis (RA) patients for type II collagen (CII) epitopes that are arthritogenic in collagen‐induced …
arthritis (RA) patients for type II collagen (CII) epitopes that are arthritogenic in collagen‐induced …
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis
…, L Fugger, J Kihlberg, H Burkhardt… - Proceedings of the …, 2002 - National Acad Sciences
Rheumatoid arthritis (RA) is associated with certain MHC class II alleles and is characterized
by a chronic autoimmune response in the joints. Using transgenic mice expressing human …
by a chronic autoimmune response in the joints. Using transgenic mice expressing human …
[HTML][HTML] Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
…, MA Brown, P Ho, F Behrens, H Burkhardt… - Nature …, 2015 - nature.com
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis and,
despite the larger estimated heritability for PsA, the majority of genetic susceptibility loci …
despite the larger estimated heritability for PsA, the majority of genetic susceptibility loci …
T cell recognition of carbohydrates on type II collagen.
…, S Reis, Å Engström, H Burkhardt… - The Journal of …, 1994 - rupress.org
A critical event in an immune response is the T cell recognition of peptides bound to major
histocompatibility complex (MHC) molecules on the surface of an antigen presenting cell (APC…
histocompatibility complex (MHC) molecules on the surface of an antigen presenting cell (APC…
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results …
…, AJ Schottelius, H Burkhardt - Annals of the …, 2015 - ard.bmj.com
Objectives To determine the safety, tolerability and signs of efficacy of MOR103, a human
monoclonal antibody to granulocyte–macrophage colony-stimulating factor (GM-CSF), in …
monoclonal antibody to granulocyte–macrophage colony-stimulating factor (GM-CSF), in …
Autoimmune priming, tissue attack and chronic inflammation—T he three stages of rheumatoid arthritis
…, V Malmström, H Burkhardt - European journal of …, 2014 - Wiley Online Library
Extensive genome‐wide association studies have recently shed some light on the causes of
chronic autoimmune diseases and have confirmed a central role of the adaptive immune …
chronic autoimmune diseases and have confirmed a central role of the adaptive immune …